tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RLAY Stock Latest News

Relay Therapeutics Holds 2025 Annual Stockholder Meeting
Company AnnouncementsRelay Therapeutics Holds 2025 Annual Stockholder Meeting
3d ago
8K
RLAY
Relay Therapeutics Announces Lease Termination Agreement
PremiumCompany Announcements
Relay Therapeutics Announces Lease Termination Agreement
5d ago
8K
RLAY
Relay Therapeutics announces updated data for RLY-2608 with Fulvestrant
PremiumThe Fly
Relay Therapeutics announces updated data for RLY-2608 with Fulvestrant
8d ago
RLAY
Relay Therapeutics price target lowered to $10 from $30 at Guggenheim
PremiumThe Fly
Relay Therapeutics price target lowered to $10 from $30 at Guggenheim
1M ago
RLAY
3 Best Stocks to Buy Now, 5/7/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 5/7/2025, According to Top Analysts
1M ago
ALAB
PRTH
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
PremiumThe FlyOncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
1M ago
IDYA
NRIX
Relay Therapeutics: Awaiting Significant Catalysts Amidst Strong Cash Position and Pipeline Potential
Premium
Ratings
Relay Therapeutics: Awaiting Significant Catalysts Amidst Strong Cash Position and Pipeline Potential
1M ago
RLAY
Relay Therapeutics Extends Cash Runway and Advances Clinical Trials
Premium
Company Announcements
Relay Therapeutics Extends Cash Runway and Advances Clinical Trials
1M ago
RLAY
Relay Therapeutics reports Q1 EPS (46c), consensus (48c)
PremiumThe Fly
Relay Therapeutics reports Q1 EPS (46c), consensus (48c)
1M ago
RLAY
Is RLAY a Buy, Before Earnings?
PremiumPre-Earnings
Is RLAY a Buy, Before Earnings?
1M ago
RLAY
Relay Therapeutics initiated with an Equal Weight at Wells Fargo
PremiumThe Fly
Relay Therapeutics initiated with an Equal Weight at Wells Fargo
2M ago
RLAY
Strategic Operational Changes and Financial Stability Bolster Relay Therapeutics’ Buy Rating
PremiumRatings
Strategic Operational Changes and Financial Stability Bolster Relay Therapeutics’ Buy Rating
2M ago
RLAY
Relay Therapeutics weakness brings buying opportunity, says Barclays
PremiumThe FlyRelay Therapeutics weakness brings buying opportunity, says Barclays
2M ago
RLAY
Relay Therapeutics weakness brings buying opportunity, says Barclays
Premium
The Fly
Relay Therapeutics weakness brings buying opportunity, says Barclays
2M ago
RLAY
Relay Therapeutics: Promising Clinical Trials and Strategic Positioning Justify Buy Rating
Premium
Ratings
Relay Therapeutics: Promising Clinical Trials and Strategic Positioning Justify Buy Rating
3M ago
RLAY
Buy Rating for Relay Therapeutics Amid Strategic Clinical Progress and Resource Optimization
PremiumRatings
Buy Rating for Relay Therapeutics Amid Strategic Clinical Progress and Resource Optimization
3M ago
RLAY
Relay Therapeutics price target lowered to $12 from $21 at Citizens JMP
PremiumThe Fly
Relay Therapeutics price target lowered to $12 from $21 at Citizens JMP
3M ago
RLAY
Buy Rating for Relay Therapeutics Driven by Strategic Advancements and Promising Clinical Trial Developments
PremiumRatings
Buy Rating for Relay Therapeutics Driven by Strategic Advancements and Promising Clinical Trial Developments
3M ago
RLAY
Relay Therapeutics Reports 2024 Financial Results and Progress
PremiumCompany Announcements
Relay Therapeutics Reports 2024 Financial Results and Progress
3M ago
RLAY
Relay Therapeutics reports Q4 EPS (45c), consensus (55c)
PremiumThe FlyRelay Therapeutics reports Q4 EPS (45c), consensus (55c)
3M ago
RLAY
Relay Therapeutics Inc (RLAY) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Relay Therapeutics Inc (RLAY) Q4 Earnings Cheat Sheet
4M ago
RLAY
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
Premium
The Fly
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
5M ago
ABT
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >